Ana Stankovic is a Nephrology physician affiliated with Seven Bridges Genomics. OpenAlex indexes 14 publications with 411 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
31 Stiles Rd Ste 2400
Salem, NH 03079
Telephone
603-890-2771Provider last certified this registry record 16 Dec 2020.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
- Bayer HealthCare Pharmaceuticals Inc.Program year202214 payments$12,346openpaymentsdata.cms.gov ↗
- Sage Therapeutics, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Calcium channel blocker20%Amlodipine Besylate100%Part D≥64 patientsAngiotensin receptor blocker (ARB)11.7%Losartan Potassium63%Olmesartan Medoxomil19%Valsartan18%Part D<11 patients+ 7 more classes in this area
Musculoskeletal
8.2%Xanthine oxidase inhibitor6.4%Allopurinol100%Part D≥24 patientsAlkaloid1.8%Colchicine100%Part D<11 patientsMetabolism & gastrointestinal
5.7%Metabolic Alkalinizer3.9%Potassium Citrate Er100%Part D≥15 patientsPotassium supplement1.8%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Benchmarking challenging small variants with linked and long reads
bioRxiv (Cold Spring Harbor Laboratory)
2020 - Quantitative Microscopy Reveals Centromeric Chromatin Stability, Size, and Cell Cycle Mechanisms to Maintain Centromere Homeostasis
Progress in molecular and subcellular biology
2017 - Cell cycle-based mechanism of epigenetic centromere propagation
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”